KinasePro

Kinase Chemistry – Just a year and a half behind the times.

Archive for the ‘Deals’ Category

News of the day

Posted by kinasepro on November 14, 2007

 O=C(N([H])C2=CC=C(C3=CN4C(SC5=CC(N6CCN(C)CC6)=CC=C45)=N3)C=C2)N([H])C1=NOC(C(C)(C)C)=C1

aetiology and limited data in: WO/2005/048953

Advertisements

Posted in Ambit, Aurora, Deals, Flt3, Rigel | 16 Comments »

Array: Bag ‘o’ cash en route

Posted by kinasepro on September 25, 2007

40M up front:

…Array will grant Celgene an option to select drugs developed under the collaboration that are directed to two of four mutually selected discovery targets

Looks like unpartnerds include: KSP, P38, P38/tie2, Erbb1-2RAF, TLR’s, etc

Posted in Array, Celgene, Deals | Leave a Comment »

ARQ-197

Posted by kinasepro on April 27, 2007

Hard to spit in the sink at ‘30 million for the Asian rights‘ to a ph1 compound…

O=C(NC1=O)[C@](C2=CNC3=C2C=CC=C3)([H])[C@@]1([H])C4=CN5C6=C4C=CC=C6CCC5

WO/2006/086484

Posted in c-Met, Deals | Leave a Comment »

XL518

Posted by kinasepro on January 4, 2007

>> update >>   An Exelixis Mek application WO/2007/044515 published 4/19/07

So did the IND and deal actually beat the patent application? Either that or I’m missing something, because I can’t find it.

“XL518 is the second Exelixis compound designed to inhibit the RAS/RAF/MEK/ERK pathway with high potency and specificity, and the first to specifically target MEK,”

They’ve got an interesting RAF application in the stable, but I was under the impression that was the one to house the XL281 series.

hat tip: Xcovery, but of course.

Posted in Deals, Exelixis, Genentech, MEK | 2 Comments »

Wyeth gets Jak’d up!

Posted by kinasepro on December 30, 2006

via Jak3 but of course – in an underanounced deal with Pharmacopeia:

…Wyeth will pay Pharmacopeia $5 million initially, as much as $9 million of research funding over the next three years, and as much as $175 million for reaching certain goals with the JAK3 kinase inhibitor drug.

While it’s likely they have a few which haven’t published yet, WO/2006/108103 is the most recent PCOP Jak3 application.

O=C1NC2=C(N=C(N3C4=CC(F)=CC=C4N=C3)N=C2)N1[C@H]5CCC(C6=C5C=CC=C6)=O

They’ve been at this stuff for a while – I reckon since WO/2001/047921 and have a recent Tet Lett on a related series. Check 2HK5 for a clue on how they bind.

>> update 1/25/07 >> US20070021443 Jak3 Pharmacopeia patent application

Posted in Deals, JAK, Pharmacopeia, Wyeth | 3 Comments »